![](/img/cover-not-exists.png)
Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes
van der Jagt, RichardVolume:
6
Language:
english
Journal:
Expert Review of Hematology
DOI:
10.1586/17474086.2013.841538
Date:
October, 2013
File:
PDF, 413 KB
english, 2013